Cardiac safety of intraoperative fluid therapy regimens in patients with concomitant coronary heart disease during major abdominal surgery
DOI:
https://doi.org/10.14739/2310-1210.2021.2.217280Keywords:
infusion therapy, biomarkers of myocardial damage, cardiac safetyAbstract
Myocardial biomarkers such as brain natriuretic peptide (BNP) and brain natriuretic peptide amino-terminal prohormone (NT-proBNP), cardiac troponins (cTn), C-reactive protein (CRP) are considered as key in the strategy of treatment and prognosis for cardiovascular diseases. It is relevant for patients with high cardiological risk during major abdominal surgery and important in the context of preventing cardiac complications in the perioperative period.
The aim. To assess the cardiac safety of intraoperative fluid therapy regimens in patients with high cardiac risk after major abdominal surgery by analyzing the dynamics of NTproBNP, Troponin I and CRP indicators.
Materials and methods. The study included 89 patients who were divided into two groups depending on the tactics of the intraoperative fluid therapy: liberal and relatively restrictive. Continuous monitoring of macroindicators of cardiovascular system, quantitative assessment of myocardial damage biomarkers (TnI, NTproBNP) and CRP by enzyme-linked immunosorbent assay were performed at three stages - before surgery, immediately after and in the first 18–24 hours.
Results. The rate of intraoperative fluid therapy was significantly different in two groups: in the restrictive 7.0 ± 0.2 ml/kg/h (n = 45), liberal 13.9 ± 0.6 ml/kg/h (n = 44). Evaluation of the dynamics of myocardial damage biomarkers revealed no differences in the levels of Troponin I and NP-proBNP at the first stage of the study. In the early postoperative period, the level of NP-proBNP in the second group was significantly higher than that in the first, 123.1 pg/ml and 68.0 pg/ml, respectively. An increase in Troponin I levels in the postoperative period was detected in 5 patients of the first group and in 6 – of the second, and it was diagnosed as myocardial injury after noncardiac surgery (MINS).
Conclusions. The study has demonstrated the relative safety of fluid therapy regimens in patients with concomitant coronary heart disease without manifestations of congestive heart failure during major abdominal surgery. The regimen with relative fluid restriction has appeared to be preferable due to less response induction from compensatory mechanisms with normal NT-proBNP values. Adequate monitoring of cardiovascular system parameters and control of the dynamics of myocardial damage biomarkers can be the key in preventing such severe complications as postoperative myocardial infarction.
References
Vascular Events In Noncardiac Surgery Patients Cohort Evaluation (VISION) Study Investigators, Devereaux, P. J., Chan, M. T., Alonso-Coello, P., Walsh, M., Berwanger, O., Villar, J. C., Wang, C. Y., Garutti, R. I., Jacka, M. J., Sigamani, A., Srinathan, S., Biccard, B. M., Chow, C. K., Abraham, V., Tiboni, M., Pettit, S., Szczeklik, W., Lurati Buse, G., Botto, F., … Yusuf, S. (2012). Association Between Postoperative Troponin Levels and 30-Day Mortality Among Patients Undergoing Noncardiac Surgery. JAMA, 307(21), 2295-2304. https://doi.org/10.1001/jama.2012.5502
POISE Study Group, Devereaux, P. J., Yang, H., Yusuf, S., Guyatt, G., Leslie, K., Villar, J. C., Xavier, D., Chrolavicius, S., Greenspan, L., Pogue, J., Pais, P., Liu, L., Xu, S., Málaga, G., Avezum, A., Chan, M., Montori, V. M., Jacka, M., & Choi, P. (2008). Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. The Lancet, 371(9627), 1839-1847. https://doi.org/10.1016/S0140-6736(08)60601-7
Protasov, K. V. (2015). Serdechno-sosudistye oslozhneniya v ekstrakardial'noi khirurgii [Cardiovascular complications in extracardiac surgery]. RIO GBOU DPO IGMAPO. [in Russian].
Smilowitz, N. R., & Berger, J. S. (2020). Perioperative Cardiovascular Risk Assessment and Management for Noncardiac Surgery: A Review. JAMA, 324(3), 279-290. https://doi.org/10.1001/jama.2020.7840
Sepehri Shamloo, A., Arya, A., Darma, A., Nedios, S., Döring, M., Bollmann, A., Dagres, N., & Hindricks, G. (2020). Atrial fibrillation: is there a role for cardiac troponin? Diagnosis. https://doi.org/10.1515/dx-2019-0072
Clerico, A., Passino, C., Franzini, M., & Emdin, M. (2015). Cardiac biomarker testing in the clinical laboratory: Where do we stand? General overview of the methodology with special emphasis on natriuretic peptides. Clinica Chimica Acta, 443, 17-24. https://doi.org/10.1016/j.cca.2014.06.003
Thygesen, K., Alpert, J. S., Jaffe, A. S., Chaitman, B. R., Bax, J. J., Morrow, D. A., White, H. D., & Executive Group on behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction. (2018). Fourth Universal Definition of Myocardial Infarction (2018). Journal of the American College of Cardiology, 72(18), 2231-2264. https://doi.org/10.1016/j.jacc.2018.08.1038
Oluleye, O. W., Folsom, A. R., Nambi, V., Lutsey, P. L., Ballantyne, C. M., & ARIC Study Investigators. (2013). Troponin T, B-type natriuretic peptide, C-reactive protein, and cause-specific mortality. Annals of Epidemiology, 23(2), 66-73. https://doi.org/10.1016/j.annepidem.2012.11.004
van Boven, N., Battes, L. C., Akkerhuis, K. M., Rizopoulos, D., Caliskan, K., Anroedh, S. S., Yassi, W., Manintveld, O. C., Cornel, J. H., Constantinescu, A. A., Boersma, E., Umans, V. A., & Kardys, I. (2018). Toward personalized risk assessment in patients with chronic heart failure: Detailed temporal patterns of NT-proBNP, troponin T, and CRP in the Bio-SHiFT study. American Heart Journal, 196, 36-48. https://doi.org/10.1016/j.ahj.2017.10.008
Rodseth, R. N., Biccard, B. M., Le Manach, Y., Sessler, D. I., Lurati Buse, G. A., Thabane, L., Schutt, R. C., Bolliger, D., Cagini, L., Cardinale, D., Chong, C. P., Chu, R., Cnotliwy, M., Di Somma, S., Fahrner, R., Lim, W. K., Mahla, E., Manikandan, R., Puma, F., Pyun, W. B., … Devereaux, P. J. (2014). The prognostic value of pre-operative and post-operative B-type natriuretic peptides in patients undergoing noncardiac surgery: B-type natriuretic peptide and N-terminal fragment of pro-B-type natriuretic peptide: a systematic review and individual patient data meta-analysis. Journal of the American College of Cardiology, 63(2), 170-180. https://doi.org/10.1016/j.jacc.2013.08.1630
Rodseth, R. N., Lurati Buse, G. A., Bolliger, D., Burkhart, C. S., Cuthbertson, B. H., Gibson, S. C., Mahla, E., Leibowitz, D. W., & Biccard, B. M. (2011). The Predictive Ability of Pre-Operative B-Type Natriuretic Peptide in Vascular Patients for Major Adverse Cardiac Events: An Individual Patient Data Meta-Analysis. Journal of the American College of Cardiology, 58(5), 522-529. https://doi.org/10.1016/j.jacc.2011.04.018
Writing Committee for the VISION Study Investigators, Devereaux, P. J., Biccard, B. M., Sigamani, A., Xavier, D., Chan, M., Srinathan, S. K., Walsh, M., Abraham, V., Pearse, R., Wang, C. Y., Sessler, D. I., Kurz, A., Szczeklik, W., Berwanger, O., Villar, J. C., Malaga, G., Garg, A. X., Chow, C. K., Ackland, G., … Guyatt, G. H. (2017). Association of Postoperative High-Sensitivity Troponin Levels With Myocardial Injury and 30-Day Mortality Among Patients Undergoing Noncardiac Surgery. JAMA, 317(16), 1642-1651. https://doi.org/10.1001/jama.2017.4360
Shin, C. H., Long, D. R., McLean, D., Grabitz, S. D., Ladha, K., Timm, F. P., Thevathasan, T., Pieretti, A., Ferrone, C., Hoeft, A., Scheeren, T., Thompson, B. T., Kurth, T., & Eikermann, M. (2018). Effects of Intraoperative Fluid Management on Postoperative Outcomes: A Hospital Registry Study. Annals of Surgery, 267(6), 1084-1092. https://doi.org/10.1097/SLA.0000000000002220
Regenbogen, S. E., Shah, N. J., Collins, S. D., Hendren, S., Englesbe, M. J., & Campbell, D. A., Jr. (2017). Population-based Assessment of Intraoperative Fluid Administration Practices Across Three Surgical Specialties. Annals of Surgery, 265(5), 930-940. https://doi.org/10.1097/SLA.0000000000001745
Varadhan, K. K., & Lobo, D. N. (2010). A meta-analysis of randomised controlled trials of intravenous fluid therapy in major elective open abdominal surgery: getting the balance right. The Proceedings of the Nutrition Society, 69(4), 488-498. https://doi.org/10.1017/S0029665110001734
Nikorowitsch, J., Ojeda, F., Lackner, K. J., Schnabel, R. B., Blankenberg, S., Zeller, T., & Karakas, M. (2020). Head-to-Head Comparison of the Incremental Predictive Value of The Three Established Risk Markers, Hs-troponin I, C-Reactive Protein, and NT-proBNP, in Coronary Artery Disease. Biomolecules, 10(3), Аrticle 394. https://doi.org/10.3390/biom10030394
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
